Alex Sapir, President & CEO at Dova Pharmaceuticals, Inc. (DOVA), bought 20,100 shares at $17.00 ($342K) on 2017-07-05, disclosed to the SEC on 2017-07-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |